Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)
| Status: | Completed |
|---|---|
| Conditions: | Liver Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 10/21/2012 |
| Start Date: | April 2012 |
| End Date: | May 2013 |
| Contact: | Toll Free Number |
| Phone: | 1-888-577-8839 |
A Clinical Study to Characterize Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma for Utilization of Target Engagement and Pharmacodynamic Biomarkers in Future Phase I Trials
The primary purpose of this study is to characterize the baseline variability of a panel of
tissue (tumor and adjacent) and blood-based biomarkers obtained from participants with
hepatocellular carcinoma (HCC).
Inclusion Criteria:
- Diagnosed with HCC.
- Candidate for surgical resection or has no contraindications to MRI procedures.
Exclusion Criteria:
- Prior loco-regional treatment of tumor, unless there is untreated tumor present
representing a distinct untreated nodule.
- Confirmed or suspected diagnosis of fibrolamellar HCC, mixed HCC/cholangiocarcinoma
or metastatic tumor.
- Had a liver transplant.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials